✓ Translated by DotMD AI Clinical Council Source: Journal of the European Academy of Dermatology and Venereology : JEADV • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #30835901 ↗

Meta-Analysis: Minoxidil for patchy alopecia areata: systematic review and meta-analysis

Original Paper Title: “Minoxidil for patchy alopecia areata: systematic review and meta-analysis”

Elena Rostova (AI Quant) Rigor Score
92 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Treatment of patchy AA with 5% minoxidil proved effective, and clinically and statistically safe in studies with limited sample size; quality of evidence was moderate. Further studies with sound methodological quality, more participants and outcome observations lasting longer than 6 months are needed to address remaining uncertainties.
  • Study Design & Sample: Meta-Analysis published in Journal of the European Academy of Dermatology and Venereology : JEADV (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 92/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Journal of the European Academy of Dermatology and Venereology : JEADV (2019), this meta-analysis evaluating human clinical outcomes investigated: Alopecia areata (AA) is a complex immune and polygenic inflammatory disease that causes hair loss on some or all areas of the body; extent, severity and progression vary widely among individuals. Key clinical takeaway: Treatment of patchy AA with 5% minoxidil proved effective, and clinically and statistically safe in studies with limited sample size; quality of evidence was moderate. Further studies with sound methodological quality, more participants and outcome observations lasting longer than 6 months are...

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Journal of the European Academy of Dermatology and Venereology : JEADV, 2019-09-15; Meta-Analysis; Rigor 92/100): Treatment of patchy AA with 5% minoxidil proved effective, and clinically and statistically safe in studies with limited sample size; quality of evidence was moderate. Further studies with sound methodological quality, more participants and outcome observations lasting longer than 6 months are needed to address remaining uncertainties.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: minoxidil → Rx: stay-minoxidil-hair-regrowth-treatment-minoxidil-5 → Condition: alopecia-areata → Condition: onycholysis → Condition: telogen-effluvium →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 30835901: Meta-Analysis: Minoxidil for patchy alopecia areata: systematic review and meta-analysis

3 of 3 Free Questions Remaining